1. Dacron or ePTFE for Femoro-popliteal Above-Knee Bypass Grafting: Short- and Long-term Results of a Multicentre Randomised Trial
- Author
-
J. van der Palen, Robert H. Geelkerken, R.J. van Det, and Bianca H.R. Vriens
- Subjects
Adult ,Male ,Duplex ultrasonography ,medicine.medical_specialty ,medicine.medical_treatment ,Polyester ,Physical examination ,Arterial Occlusive Diseases ,Prosthesis ,Amputation, Surgical ,Peripheral arterial occlusive disease ,Dacron ,Ischemia ,Outcome Assessment, Health Care ,medicine ,Humans ,Popliteal Artery ,Prospective Studies ,Vein ,Polytetrafluoroethylene ,Vascular Patency ,Aged ,Aged, 80 and over ,Medicine(all) ,medicine.diagnostic_test ,business.industry ,Polyethylene Terephthalates ,Warfarin ,Intermittent Claudication ,Middle Aged ,Femoro-popliteal bypass ,Confidence interval ,Surgery ,Blood Vessel Prosthesis ,Clinical trial ,Femoral Artery ,medicine.anatomical_structure ,Peripheral bypass ,Female ,medicine.symptom ,PTFE ,business ,Claudication ,Cardiology and Cardiovascular Medicine ,medicine.drug ,Follow-Up Studies - Abstract
Objectives To compare expanded polytetrafluoroethylene (ePTFE) prosthesis and collagen-impregnated knitted polyester (Dacron) for above-knee (AK) femoro-popliteal bypass grafts. Design A prospective multicentre randomised clinical trial. Patients and Methods Between 1992 and 1996, 228 AK femoro-popliteal bypass grafts were randomly allocated to either an ePTFE ( n =114) or a Dacron ( n =114) vascular graft (6mm in diameter). Patients were eligible for inclusion if presenting with disabling claudication, rest pain or tissue loss. Follow-up was performed and included clinical examination and duplex ultrasonography at all scheduled intervals. All patients were treated with warfarin. The main end-point of this study was primary patency of the bypass graft at 2, 5 and 10 years after implantation. Secondary end-points were mortality, primary assisted patency and secondary patency. Cumulative patency rates were calculated with life-table analysis and with log-rank test. Results After 5 years, the primary, primary assisted and secondary patency rates were 36% (confidence interval (CI): 26–46%), 46% (CI: 36–56%) and 51% (CI: 41–61%) for ePTFE and 52% (CI: 42–62%) ( p =0.04), 66% (CI: 56–76%) ( p =0.01) and 70% (CI: 60–80%) ( p =0.01) for Dacron, respectively. After ten years these rates were respectively 28% (CI:18-38%), 31% (CI:19-43%) and 35% (CI: 23-47%) for ePTFE and 28% (CI: 18-38%), 49% (CI: 37-61%) and 49% (CI: 37-61%) for Dacron. Conclusion During prolonged follow-up (10 years), Dacron femoro-popliteal bypass grafts have superior patency compared to those of ePTFE grafts. Dacron is the graft material of choice if the saphenous vein is not available.
- Published
- 2009
- Full Text
- View/download PDF